Entry Point Capital, LLC Delcath Systems, Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 24,816 shares of DCTH stock, worth $395,070. This represents 0.13% of its overall portfolio holdings.
Number of Shares
24,816Holding current value
$395,070% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding DCTH
# of Institutions
79Shares Held
7.78MCall Options Held
198KPut Options Held
41.7K-
Vivo Capital, LLC Palo Alto, CA1.71MShares$27.2 Million3.93% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.39MShares$22.1 Million6.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$19.5 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA419KShares$6.66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA289KShares$4.6 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $137M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...